Impact of laser power settings on sexual and urinary outcomes in holmium laser enucleation of the prostate: a multicenter randomized controlled trial
Lasers in Medical Science · 2025
DOI: 10.1007/s10103-025-04551-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Medical Science, 2025. Verfasst von Ping Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jintan People's Hospital, Changzhou, China. Hauptthemen laut MEDLINE: Lasers, Solid-State, Prostatic Hyperplasia, Prostatectomy. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Science and Technology Project of Changzhou Health Committee.
Abstract (Originalsprache)
Holmium Laser Enucleation of the Prostate (HoLEP) has emerged as a definitive treatment for benign prostatic hyperplasia (BPH). However, the influence of laser power settings on postoperative sexual function and urinary outcomes remains controversial. This study aimed to compare high-power (HP) and low-power (LP) HoLEP in sexually active men with BPH, with a particular focus on erectile function preservation and alleviation of lower urinary tract symptoms (LUTS). In a multicenter, prospective, double-blind randomized controlled trial, 200 sexually active male patients with symptomatic BPH refractory to medical therapy were enrolled and randomly assigned to either HP-HoLEP or LP-HoLEP. Primary outcomes were assessed via changes in the International Index of Erectile Function (IIEF-5) and International Prostate Symptom Score (IPSS) at 1, 3, and 6 months postoperatively. Secondary endpoints included measurements of maximum urinary flow rate (Qmax), detailed operative parameters, and postoperative complications classified according to the Clavien-Dindo system. A total of 184 patients completed the study (HP group, n = 94; LP group, n = 90). Both groups exhibited significant postoperative improvements in LUTS and Qmax. A transient decline in IIEF-5 scores was observed at 1 month, with full recovery by the 3-month follow-up; no significant differences in erectile function were found between the groups at any time point. Notably, the LP group experienced longer enucleation and overall operation times but reported lower early postoperative pain scores. The complication profiles were similar between the two cohorts. Both HP-HoLEP and LP-HoLEP provide effective relief of BPH symptoms while maintaining long-term sexual function in sexually active men. The choice of laser power settings may be tailored according to patient characteristics and surgeon preference without compromising clinical outcomes. Future large-scale studies are recommended to validate these results across diverse clinical settings.Clinical Trial Registration Registration was completed on the China National Universal Health Insurance Information Platform under the identifier MR-32-20-004219.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jintan People's Hospital, Changzhou, China.
- Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
- Institute of Life Sciences of Southeast University, Nanjing, China.
- Jiangdu People's Hospital Affiliated to Yangzhou University, Yangzhou, China. wangrong2024@suda.edu.cn.
Förderung
- Science and Technology Project of Changzhou Health Committee
Zitieren
APA
Wang, P., Shen, Y., Hou, A., & Wang, R. (2025). Impact of laser power settings on sexual and urinary outcomes in holmium laser enucleation of the prostate: a multicenter randomized controlled trial. Lasers in Medical Science. https://doi.org/10.1007/s10103-025-04551-3
Vancouver
Wang P, Shen Y, Hou A, Wang R. Impact of laser power settings on sexual and urinary outcomes in holmium laser enucleation of the prostate: a multicenter randomized controlled trial. Lasers in Medical Science. 2025. doi:10.1007/s10103-025-04551-3
BibTeX
@article{Wang2025,
author = {Wang, Ping and Shen, Yajun and Hou, Anman and Wang, Rong},
title = {Impact of laser power settings on sexual and urinary outcomes in holmium laser enucleation of the prostate: a multicenter randomized controlled trial},
journal = {Lasers in Medical Science},
year = {2025},
doi = {10.1007/s10103-025-04551-3}
}
EUVIMED